Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0636 CHF | +4.26% | +8.16% | +55.12% |
05-01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
04-17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+55.12% | 4.56M | |
-2.56% | 88.14B | |
+3.29% | 40.44B | |
-15.40% | 32.24B | |
+51.96% | 24.39B | |
-14.35% | 15.59B | |
-39.65% | 12.3B | |
-6.52% | 12.18B | |
-13.41% | 12.14B | |
+5.17% | 8.87B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Polyphor Finalizes Merger With EnBiotix, to Change Name to Spexis